Core Scientific, Inc. Common Stock

CORZ

Market cap $28.1M

Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW YORK , Oct. 17, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ: CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ: CRWV) on the terms announced on July 7, 2025. The full text of the letter is below.

LIVINGSTON, N.J.--(BUSINESS WIRE)--CoreWeave Inc. (NASDAQ: CRWV), The Essential Cloud for AI, today released the following open letter to stockholders of Core Scientific, Inc. (NASDAQ: CORZ). The letter reaffirms CoreWeave's commitment to the proposed acquisition of Core Scientific on the previously agreed terms and corrects inaccurate and misleading statements made by Two Seas Capital (“Two Seas”), an event-driven hedge fund specializing in litigation. Dear Core Scientific Stockholders, CoreWe.

Core Scientific's board urged its shareholders on Wednesday to vote for the company's proposed sale to CoreWeave.

Highlights Transaction's Flawed Process, Deficient Structure and Inadequate Price Urges Shareholders to Vote AGAINST the Proposed Transaction NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ: CORZ), today released an investor presentation, which was filed with the SEC on Friday, October 10, in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ: CRWV) on the terms announced on July 7, 2025. The full presentation can be found HERE.

Core Scientific hits a new high in Friday's stock market.

CoreWeave doesn't plan to change its bid for Core Scientific, according to CoreWeave's CEO Michael Intrator. Intrator discusses compute demand and the company's M&A strategy with Caroline Hyde and Ed Ludlow on “Bloomberg Tech.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Core Scientific, Inc. (NasdaqGS: CORZ) to CoreWeave, Inc. (NasdaqGS: CRWV). Under the terms of the proposed transaction, shareholders of Core Scientific will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific that they own. KSF is seeking to determ.

NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ: CORZ), today announced that it has filed its definitive proxy statement with the Securities and Exchange Commission ("SEC") in connection to its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ: CRWV) on the terms announced on July 7, 2025.

SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is continuing its investigation into whether the board members of Core Scientific, Inc. (NasdaqGS: CORZ) breached their fiduciary duties in connection with the proposed sale of the company to CoreWeave, Inc. (NasdaqGS: CRWV).

CoreWeave stock has dropped back, putting its deal for Core Scientific at risk. A renegotiation seems likely.